Join our host, Larry Zeifman and this week's guests, David Wood, PhD, Partner at BLG and Spencer Hawkswell, CEO at Therapsil - together they discuss CDSA exemptions, Therapsil's work within the psychedelics industry and the future of regulations for psychedelics as medication for mental health treatment.
Share this post
